Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Condition(s):Genital Herpes Simplex Type 2Last Updated:May 22, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Genital Herpes Simplex Type 2Last Updated:May 22, 2018Completed
Condition(s):Covid-19 Pandemics; TuberculosisLast Updated:June 23, 2023Enrolling by invitation
Condition(s):Systemic Lupus Erythematosus; Antiphospholipid SyndromeLast Updated:April 6, 2023Recruiting
Condition(s):Acute Coronary Syndromes; STEMI; NSTEMILast Updated:January 29, 2015Unknown status
Condition(s):COVID-19Last Updated:March 14, 2022Completed
Condition(s):Non-small Cell Lung CancerLast Updated:February 22, 2024Completed
Condition(s):Skin Graft ComplicationsLast Updated:December 16, 2016Withdrawn
Condition(s):Acute Coronary SyndromeLast Updated:March 23, 2017Completed
Condition(s):COVID-19 Infection; COVID-19 VACCINELast Updated:July 6, 2022Completed
Condition(s):STEMI; Large Thrombus Burden; No-Reflow PhenomenonLast Updated:August 31, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.